gadolinium dtpa has been researched along with Adenoma, Islet Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cumming, MJ; Greenberg, HM; Kroeker, MA; Magro, CM; Semelka, RC; Shoenut, JP; Yaffe, CS | 1 |
| Chan, R; Do, NK; Mueller-Lisse, UG; Shyn, PB; Thoeni, RF | 1 |
2 other study(ies) available for gadolinium dtpa and Adenoma, Islet Cell
| Article | Year |
|---|---|
Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adenoma, Islet Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed | 1993 |
Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity.
Topics: Adenoma, Islet Cell; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2000 |